Avenue Therapeutics, Inc.
ATXI
$0.58
-$0.01-1.70%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 1.40M | -- | -- | -- | -- |
| Total Revenue | 1.40M | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.40M | -- | -- | -- | -- |
| SG&A Expenses | 4.27M | 4.82M | 4.64M | 4.74M | 5.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.76M | 9.48M | 11.28M | 11.81M | 10.72M |
| Operating Income | -6.36M | -9.48M | -11.28M | -11.81M | -10.72M |
| Income Before Tax | -6.18M | -9.21M | -11.70M | -9.52M | -5.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.18 | -9.21 | -11.70 | -9.52 | -5.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 38.00K | 41.00K | 44.00K | 52.00K | 54.00K |
| Net Income | -6.14M | -9.16M | -11.65M | -9.47M | -5.87M |
| EBIT | -6.36M | -9.48M | -11.28M | -11.81M | -10.72M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 1.39 | -5.14 | -19.92 | -21.46 | -14.67 |
| Normalized Basic EPS | -2.03 | -3.60 | -8.03 | -6.06 | -1.77 |
| EPS Diluted | 1.39 | -5.14 | -19.92 | -21.46 | -14.67 |
| Normalized Diluted EPS | -2.03 | -3.60 | -8.03 | -6.06 | -1.77 |
| Average Basic Shares Outstanding | 9.65M | 7.58M | 5.18M | 3.56M | 2.07M |
| Average Diluted Shares Outstanding | 9.65M | 7.58M | 5.18M | 3.56M | 2.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |